Atossa Genetics, Inc. Prices $4,000,000 Public Offering
29. März 2017 01:50 ET
|
Atossa Genetics, Inc.
SEATTLE, WA--(Marketwired - Mar 29, 2017) - Atossa Genetics, Inc. (NASDAQ: ATOS), today announced the pricing of an underwritten public offering with anticipated gross proceeds of $4,000,000,...
Atossa Genetics Opens Enrollment in Study of Endoxifen
23. März 2017 08:41 ET
|
Atossa Genetics, Inc.
SEATTLE, WA--(Marketwired - Mar 23, 2017) - Atossa Genetics Inc. (NASDAQ: ATOS) today announced that it has opened enrollment of a Phase 1 study of endoxifen, which is an active metabolite of...
Atossa Genetics Provides Update on its Phase 2 Study of Fulvestrant Administered with its Microcatheter
09. Januar 2017 08:15 ET
|
Atossa Genetics, Inc.
SEATTLE, WA--(Marketwired - Jan 9, 2017) - Atossa Genetics Inc. (NASDAQ: ATOS) today announced that it is transferring the site of its Phase 2 study of fulvestrant administered with its patented...
Atossa Genetics to Present at the 9th Annual Biotech Showcase Conference on January 9, 2017
05. Januar 2017 16:01 ET
|
Atossa Genetics, Inc.
SEATTLE, WA--(Marketwired - Jan 5, 2017) - Atossa Genetics, Inc. (NASDAQ: ATOS) today announced that Kyle Guse, CFO and General Counsel, will be a featured presenter at the 9th annual Biotech...
Atossa Genetics Appoints Jack Cuzick, PhD, FRS, FMedSci, FRCP (hon) as Scientific Advisor
23. Dezember 2016 08:15 ET
|
Atossa Genetics, Inc.
SEATTLE, WA--(Marketwired - Dec 23, 2016) - Atossa Genetics, Inc. (NASDAQ: ATOS) today announced that Jack Cuzick, PhD, FRS, FMedSci, FRCP (hon), has been appointed as Scientific Advisor.
...
Atossa Genetics to Present at the 9th Annual LD Micro Main Event Conference on December 7, 2016
01. Dezember 2016 08:00 ET
|
Atossa Genetics, Inc.
SEATTLE, WA--(Marketwired - Dec 1, 2016) - Atossa Genetics, Inc. (NASDAQ: ATOS) announced today that Kyle Guse, CFO and General Counsel, will be a featured presenter at the 9th annual LD Micro Main...
Atossa Genetics Announces Third Quarter 2016 Financial Results and Provides Company Update
14. November 2016 16:01 ET
|
Atossa Genetics, Inc.
SEATTLE, WA--(Marketwired - Nov 14, 2016) - Atossa Genetics Inc. (NASDAQ: ATOS) today announced Third Quarter ended September 30, 2016 financial results and provided an update on recent company...
Atossa Genetics to Provide Company Update and Discuss Third Quarter 2016 Financial Results on Conference Call on Monday, November 14, 2016
10. November 2016 08:15 ET
|
Atossa Genetics, Inc.
SEATTLE, WA--(Marketwired - Nov 10, 2016) - Atossa Genetics, Inc. (NASDAQ: ATOS) announced today that it will provide a Company update and discuss third quarter 2016 financial results on Monday,...
Atossa Genetics Inc. to Present at Upcoming Investor Conferences in October 2016
14. Oktober 2016 11:22 ET
|
Atossa Genetics, Inc.
SEATTLE, WA--(Marketwired - Oct 14, 2016) - Atossa Genetics Inc. (NASDAQ: ATOS), today announced it would be a featured presenter at the SeeThru Equity Fall Microcap Investor Conference being...
Atossa Genetics, Inc. Regains Compliance With NASDAQ Listing Requirement
13. September 2016 08:00 ET
|
Atossa Genetics, Inc.
SEATTLE, WA--(Marketwired - Sep 13, 2016) - Atossa Genetics, Inc. (NASDAQ: ATOS) today announced it has received notice from NASDAQ that Atossa has regained compliance with NASDAQ minimum...